Promiscuous antigen presentation by the nonclassical MHC Ib Qa-2 is enabled by a shallow, hydrophobic groove and self-stabilized peptide conformation
about
Characterisation of RT1-E2, a multigenic family of highly conserved rat non-classical MHC class I molecules initially identified in cells from immunoprivileged sitesStructure of a pheromone receptor-associated MHC molecule with an open and empty grooveAn MHC class Ib-restricted CD8 T cell response confers antiviral immunityCutting edge: shift in antigen dependence by an antiviral MHC class Ib-restricted CD8 T cell response during persistent viral infectionCrystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface.Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.MHC class Ib-restricted CD8 T cells differ in dependence on CD4 T cell help and CD28 costimulation over the course of mouse polyomavirus infectionIn vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib moleculesPeptide immunization elicits polyomavirus-specific MHC class ib-restricted CD8 T cells in MHC class ia allogeneic mice.The role of tapasin in MHC class I protein trafficking in embryos and T cells.Expression and alternative splicing of classical and nonclassical MHCI genes in the hippocampus and neuromuscular junction.Activation of T cells by cross-linking Qa-2, the ped gene product, requires Fyn.Immunity to polyomavirus infection: the polyomavirus-mouse model.Promiscuity of MHC class Ib-restricted T cell responses.The role of MHC class Ib-restricted T cells during infection.Recognition of the Major Histocompatibility Complex (MHC) Class Ib Molecule H2-Q10 by the Natural Killer Cell Receptor Ly49C.Evidence for MR1 antigen presentation to mucosal-associated invariant T cells.
P2860
Q24794781-1C33752E-A282-4FDC-BD18-96768E0206C6Q24816484-C6FDD0C9-40C7-4A59-8A79-A38EC9BA340FQ28510308-986A998D-915B-468D-9BCD-CFA8538476A6Q33819178-3DC6B981-14C6-4C1B-8A73-772F22C19105Q33927547-D599FD62-0939-4205-864D-0049B8E6566AQ35099713-6233225D-1303-48F3-85FE-8F1D7D1013C3Q35851023-51D7F3E3-191A-402C-A09B-BE2753101A56Q36228447-FB3F13C3-5C20-40DC-8AAE-26F6DEAA6D4DQ36626711-B760CBBE-7E3A-4836-BEAF-53D74D61CD94Q36761696-F1FBDF86-1DF6-4D72-8D86-764D04ADC022Q36767935-24F9A39E-04AA-4EB6-9746-15FF8F0C1F62Q36862970-5AA89914-C070-42EE-B7B7-68CFC6C9A08FQ37223886-AF58EA9B-2F67-45BF-B37B-196057A2F4ABQ37469136-70A66891-2AF7-4495-8A37-999F449C5661Q38883507-9D28AA50-6EF5-49D9-8174-70EA7AC32ED4Q39626004-7E9B8C9F-C120-4A90-8D24-65F5C719D6A6Q40440555-EA031806-7E5C-470C-BE6B-F793B49D1E60
P2860
Promiscuous antigen presentation by the nonclassical MHC Ib Qa-2 is enabled by a shallow, hydrophobic groove and self-stabilized peptide conformation
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Promiscuous antigen presentati ...... tabilized peptide conformation
@ast
Promiscuous antigen presentati ...... tabilized peptide conformation
@en
Promiscuous antigen presentati ...... tabilized peptide conformation
@nl
type
label
Promiscuous antigen presentati ...... tabilized peptide conformation
@ast
Promiscuous antigen presentati ...... tabilized peptide conformation
@en
Promiscuous antigen presentati ...... tabilized peptide conformation
@nl
prefLabel
Promiscuous antigen presentati ...... tabilized peptide conformation
@ast
Promiscuous antigen presentati ...... tabilized peptide conformation
@en
Promiscuous antigen presentati ...... tabilized peptide conformation
@nl
P2093
P1433
P1476
Promiscuous antigen presentati ...... tabilized peptide conformation
@en
P2093
P304
P356
10.1016/S0969-2126(01)00689-X
P577
2001-12-01T00:00:00Z